|View printer-friendly version|
Current estimates have the Company expecting to achieve its guidance
"The second quarter was another solid quarter for ZixCorp and we are on
target to report within the range of our previously-issued guidance," said
Spurr. "Preliminary estimates are that we should meet our revenue guidance of
"In its Email Encryption business, ZixCorp delivered a record
About the Company's e-Prescribing business, Spurr said, "Following the earlier announcement that ZixCorp is reviewing strategic alternatives for its e-Prescribing service, we continue with business as usual with respect to executing our existing contracts and providing services to our customers. Our PocketScript business achieved our e-Prescribing deployment guidance for the second quarter with approximately 325 deployments. ZixCorp processed over 2.5 million scripts in the quarter, an increase of approximately 19 percent compared with the same quarter in 2008. In light of our announcement concerning the assessment of this business, we are no longer in negotiations for a large contract with a national payor that could have almost doubled the number of currently active prescribers. We are, however, engaged in payor discussions to improve the profitability of our e-Prescribing business through new pricing arrangements and service enhancements."
ZixCorp to Announce Second Quarter 2009 Results on
The Company's second quarter 2009 operating results will be released after
close of the U.S. financial markets on
A live Webcast of the conference call will be available on the investor
relations portion of ZixCorp's Web site at http://investor.zixcorp.com.
Alternatively, participants can listen to the conference call by dialing
617-213-8064 or toll-free 866-770-7051 and entering access code 40200276. An
audio replay of the conference will be available until
Safe Harbor Statement for ZixCorp
The following is a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. Many of the foregoing statements by Mr. Spurr are forward-looking statements, not a guarantee of future performance, and involve substantial risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements. These risks and uncertainties include, but are not limited to, the following: the fact that the preliminary financial results included in this press release could be subject to change based on adjustments that are deemed appropriate by the Company during the process of finalizing its quarterly financial statements; the Company's continued operating losses and its PocketScript e-Prescribing service's use of cash resources; the Company's ability to achieve broad market acceptance for the Company's products and services, including the Company's ability to enter into new or expand existing sponsorship agreements for its PocketScript e-Prescribing business and the Company's ability to continue realizing acceptance of its Email Encryption business in its core markets of healthcare and financial and to achieve market acceptance of its Email Encryption business in other markets; the Company's ability to maintain existing and generate other revenue opportunities, including fees for scripts written or value added services for its payor customers from its PocketScript e-Prescribing business; the Company's ability to establish and maintain strategic and OEM relationships to gain customers and grow revenues, particularly in its Email Encryption business; the expected increase in competition in the Company's Email Encryption and e-Prescribing businesses; the Company's ability to successfully and timely introduce new Email Encryption and e-Prescribing products and services or related products and services and implement technological changes; and whether the Company will enter into a strategic transaction with respect to its e-Prescribing business and the effects of any such transaction on the Company and its stockholders. Further details pertaining to such risks and uncertainties may be found in the Company's public filings with the SEC. The Company does not intend, and undertakes no obligation, to update or revise any forward-looking statement, except as required by federal securities regulations.
firstname.lastname@example.org, or Investor Relations,